title: Biological and chemical monitoring of occupational exposure to ethylene oxide.
abstract: Studies were carried out on two populations occupationally exposed to ethylene oxide (EtO) using different physical and biological parameters. Blood samples were collected from 9 hospital workers (EI) and 15 factory workers (EII) engaged in sterilization of medical equipment with EtO and from matched controls (CI and CII). Average exposure levels during 4 months (the lifespan of erythrocytes) prior to blood sampling were estimated from levels of N-(2-hydroxyethyl)valine adducts in hemoglobin. They were significantly enhanced in EI and EII and corresponded to a 40-h time-weighted average of 0.025 ppm in EI and 5 ppm in EII. Exposures were usually received in bursts with EtO concentrations in air ranging from 22 to 72 ppm in EI and 14 to 400 ppm in EII. All samples were analyzed for HPRT mutants (MFs), chromosomal aberrations (CAs), micronuclei (MN) and SCEs. MFs were significantly enhanced by 60% in EII but not in EI. These results are the first demonstration of mutation induction in man by ethylene oxide. CAs were significantly enhanced in EI and EII by 130% and 260% respectively. MN were not enhanced in EI but significantly in EII(217%). The mean frequency of SCEs was significantly elevated by 20% in EI and by almost 100% in EII. SCE was the only parameter that allowed distinction between daily and occasionally exposed workers in EII. An interesting finding in exposed workers was the large increase of the percentage of cells with high frequencies of SCE (3-4 times in EI and 17-fold in EII). The relative sensitivity of endpoints for detection of EtO exposure in the present investigation was in the following order: HOEtVal adducts greater than SCEs greater than chromosomal aberrations greater than micronuclei greater than HPRT mutants.
authors.affiliation: MGC-Department of Radiation Genetics and Chemical Mutagenesis, State University of Leiden, The Netherlands.
authors.forename: A D
authors.initials: AD
authors.lastname: Tates
authors.forename: T
authors.initials: T
authors.lastname: Grummt
authors.forename: M
authors.initials: M
authors.lastname: Törnqvist
authors.forename: P B
authors.initials: PB
authors.lastname: Farmer
authors.forename: F J
authors.initials: FJ
authors.lastname: van Dam
authors.forename: H
authors.initials: H
authors.lastname: van Mossel
authors.forename: H M
authors.initials: HM
authors.lastname: Schoemaker
authors.forename: S
authors.initials: S
authors.lastname: Osterman-Golkar
authors.forename: C
authors.initials: C
authors.lastname: Uebel
authors.forename: Y S
authors.initials: YS
authors.lastname: Tang
mesh_terms: D000328:Adult; D002869:Chromosome Aberrations; D005027:Ethylene Oxide / Q000633:toxicity*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics; D015162:Micronucleus Tests; D008875:Middle Aged; D009152:Mutagenicity Tests; D009154:Mutation; D016273:Occupational Exposure; D012854:Sister Chromatid Exchange; D014633:Valine / Q000031:analogs & derivatives / Q000097:blood
chemical_list: D006454:Hemoglobins; C057442:2-hydroxyethylvaline; D007041:Hypoxanthine Phosphoribosyltransferase; D014633:Valine; D005027:Ethylene Oxide